bezafibrate has been researched along with Broad Beta Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 6 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inazu, A; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Nakanishi, C; Noguchi, T; Nohara, A; Tada, H; Yamagishi, M | 1 |
| Kłosiewicz-Latoszek, L; Naruszewicz, M; Nowicka, G; Szostak, WB | 2 |
| Feussner, G; Kurth, B; Lohrmann, J | 1 |
| Kobayashi, J; Morisaki, N; Murano, S; Saito, Y; Tashiro, J; Yamazaki, K | 1 |
| Holzgartner, H; Kuhn, U; Schmidt, U | 1 |
| Feussner, G; Ziegler, R | 1 |
| Hambrecht, R; Kübler, W; Schuler, G; Tischbirek, K; von Hodenberg, E | 1 |
| Bommer, J; Feussner, G; Ziegler, R | 1 |
| Clegg, RJ; Dominiczak, MH; Lorimer, AR; Packard, CJ; Shepherd, J | 1 |
3 trial(s) available for bezafibrate and Broad Beta Disease
| Article | Year |
|---|---|
Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study.
Topics: Aged; Apolipoprotein E2; Apolipoprotein E3; Atorvastatin; Bezafibrate; Chromatography, High Pressure Liquid; Cross-Over Studies; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Phenotype; Pyrroles | 2011 |
Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia.
Topics: Bezafibrate; Fenofibrate; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Lipoproteins | 1997 |
Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate.
Topics: Aged; Bezafibrate; Blood Pressure; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Garlic; Heart Rate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Male; Middle Aged; Odorants; Plants, Medicinal; Triglycerides | 1992 |
7 other study(ies) available for bezafibrate and Broad Beta Disease
| Article | Year |
|---|---|
[Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
Topics: Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 1982 |
Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone.
Topics: Aged; Bezafibrate; Cholesterol; Humans; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Hypothyroidism; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Thyroxine; Triglycerides | 1997 |
Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127----Asp, Arg158----Cys) variant.
Topics: Alleles; Apolipoproteins E; Bezafibrate; Cholesterol, Dietary; Combined Modality Therapy; Dietary Fats; Genotype; Humans; Hyperlipoproteinemia Type III; Male; Middle Aged | 1992 |
[Type III hyperlipoproteinemia in monoclonal IgM gammopathy].
Topics: Adult; Bezafibrate; Cholesterol; Dietary Fats; Female; Humans; Hypergammaglobulinemia; Hyperlipoproteinemia Type III; Immunoglobulin lambda-Chains; Immunoglobulin M; Lipids; Lovastatin; Niacin; Triglycerides | 1991 |
Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.
Topics: Apolipoproteins E; Arteriosclerosis; Bezafibrate; Cholesterol; Female; Genetic Carrier Screening; Humans; Hyperlipoproteinemia Type III; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Lipoproteins; Middle Aged; Renal Dialysis; Risk Factors; Triglycerides | 1990 |
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.
Topics: Adult; Aged; Apolipoproteins B; Bezafibrate; Female; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged | 1986 |
Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia.
Topics: Adult; Aged; Apolipoproteins B; Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Polyamines | 1987 |